FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Fosamax Plus D (Alendronate Sodium and Cholecalciferol)

Snippet

SUPPL AP for FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL)